SEARCH

SEARCH BY CITATION

References

  • Altman E, Smirnova N, Li J, Aubry A & Logan SM (2003) Occurrence of a nontypable Helicobacter pylori strain lacking Lewis blood group O antigens and dd-heptoglycan: evidence for the role of the core alpha1,6-glucan in colonization. Glycobiology 13: 777783.
  • Anderson PW, Pichichero ME, Insel RA, Betts R, Eby R & Smith DH (1986) Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol 137: 11811186.
  • Angelakopoulos H & Hohmann EL (2000) Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68: 21352141.
  • Auzanneau FI, Charon D & Szabo L (1991) Phosphorylated sugars. Part 27. Synthesis and reactions, in acid medium, of 5-O-substituted methyl 3-deoxy-α-d-manno-oct-2-ulopyranosidonic acid 4-phosphates. J Chem Soc, Perkin Trans 1: 509517.
  • Brisson J-R, Crawford E, Uhrín D, Khieu NH, Perry MB, Severn WB & Richards JC (2002) The core oligosaccharide component from Mannheimia (Pasteurella) haemolytica serotype A1 lipopolysaccharide contains l-glycero-d-manno- and d-glycero-d-manno-heptoses: analysis of the structure and conformation by high-resolution NMR spectroscopy. Can J Chem 80: 949963.
  • Castillo-Rojas G, Mazari-Hiriart M & López-Vidal Y (2004) Helicobacter pylori: focus on CagA and VacA major virulence factors. Salud pública de México 46: 538548.
  • Chandan V, Logan SM, Harrison BA, Vinogradov E, Aubry A, Stupak J, Li J & Altman E (2007) Characterization of a waaF mutant of Helicobacter pylori strain 26695 provides evidence that an extended lipopolysaccharide structure has a limited role in the invasion of gastric cancer cells. Biochem Cell Biol 85: 582590.
  • Chu C, Liu B, Watson D, Szu S, Bryla D, Shiloach J, Schneerson R & Robbins JB (1991) Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun 59: 44504458.
  • Ciucanu I & Kerek F (2004) A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131: 209217.
  • Correa P (2003) Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 2003: 238s241s.
  • Cox AD, Zou W, Gidney MAJ, Lacelle S, Plested JS, Makepeace K, Wright JC, Coull PA, Moxon ER & Richards JC (2005) Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23: 50455054.
  • Dabelsteen E, Mandel U & Clausen E (1991) Cell surface carbohydrates are markers of differentiation in human oral epithelium. Crit Rev Oral Biol Med 2: 493507.
  • Dubois M, Gilles KA, Hamilton JK, Rebers PA & Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350356.
  • Dunn BE, Cohen H & Blaser MJ (1997) Helicobacter pylori. Clin Microbiol Rev 10: 720741.
  • Eaton KA, Gilbert JV, Joyce EA, Wanken AE, Thevenot T, Baker P, Plaut A & Wright A (2002) In vivo complementation of ureB restores the ability of Helicobacter pylori to colonize. Infect Immun 70: 771778.
  • Eaton KA, Logan SM, Baker PE, Peterson RA, Monteiro MA & Altman E (2004) Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL/6J mice. Infect Immun 72: 39253931.
  • Fukuda M (1994) Cell surface carbohydrates:cell-type specific expression. Molecular Glycobiology (FukudaM & HindsgaulO, eds), pp. 152. Oxford University Press Inc, New York.
  • Gu X-X, Tsai C-M, Ueyama T, Barenkamp SJ, Robbins JB & Lim DJ (1996) Synthesis, characterization, and immunological properties of detoxified lipooligosaccharide from nontypable Haemophilus influenzae conjugated to proteins. Infect Immun 64: 40474053.
  • Haas R, Meyer TF & Van Puten JPM (1993) Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol Microbiol 8: 753760.
  • Hiratsuka K, Logan SM, Conlan JW et al. (2005) Identification of a d-glycero-d-manno-heptosyltransferase gene from Helicobacter pylori. J Bacteriol 187: 51565165.
  • Lee A, O'Rourke M, Corazon de Ungria M, Robertson B, Daskaolopoulos G & Dixon MF (1997) A standardised mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 13861397.
  • Li J & Richards JC (2007) The application of capillary electrophoresis mass spectrometry to the characterization of bacterial lipopolysaccharides. Mass Spectrom Rev 26: 3550.
  • Logan SM, Conlan JW, Monteiro MA, Wakarchuk WW & Altman E (2000) Functional genomics of Helicobacter pylori: identification of a β-1,4-galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol 35: 11561167.
  • Logan SM, Altman E, Mykytczuk O et al. (2005) Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori. Glycobiology 15: 721733.
  • Mieszala M, Kogan G & Jennings HJ (2003) Conjugation of meningococcal lipooligosaccharides through their lipid A terminus conserves their epitopes and results in conjugate vaccines having improved immunological properties. Carbohydr Res 338: 167175.
  • Monteiro MA (2001) Helicobacter pylori: a wolf in sheep's clothing: the glycotype families of Helicobacter pylori lipopolysaccharides expressing histo-blood groups: structure, biosynthesis, and role in pathogenesis. Adv Carbohydr Chem Biochem 57: 99158.
  • Passwell JH, Harlev E, Ashkenazi S et al. (2001) Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel. Infect Immun 69: 13511357.
  • Passwell JH, Ashkenazi S, Harlev E et al. (2003) Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year old children. Pediatr Infect Dis J 22: 701706.
  • Pon RA, Lussier M, Yang Q-L & Jennings HJ (1997) N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J Exp Med 185: 19291938.
  • Rossi G, Ruggiero P, Peppoloni S et al. (2004) Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Infect Immun 72: 32523259.
  • Ruggiero P, Peppoloni S, Rappuoli R & Del Giudice G (2003) The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? Microbes Infect 5: 749756.
  • Sakamoto J, Watanabe T, Tokumaru H, Takagi H, Nakazato H & Lloyd KO (1989) Expression of Lewisa, Lewisb, Lewisx, sialyl Lewisa, sialyl Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 49: 745752.
  • Sawardeker JH, Sloneker JH & Jeannes A (1967) Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal Chem 39: 16021604.
  • Schirm M, Soo EC, Aubry AJ, Austin J, Thibault P & Logan SM (2003) Structural, genetic and functional characterization of the flagellin glycosylation process in Helicobacter pylori. Mol Microbiol 48: 15791592.
  • Stead C, Tran A, Ferguson D Jr, McGrath S, Cotter R & Trent S (2005) A novel 3-deoxy-d-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide. J Bacteriol 187: 33743383.
  • Westphal O & Jann K (1965) Bacterial polysaccharides. Extraction with phenol–water and further applications of the procedure. Meth Carbohydr Chem 5: 8391.
  • Wirth HP, Yang M, Karita M & Blaser MJ (1996) Expression of the human cell surface glycoconjugates Lewis X and Lewis Y by Helicobacter pylori isolates is related to cagA status. Infect Immun 64: 45984605.
  • Yu S & Gu X-X (2007) Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis. Infect Immun 75: 29742980.